• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部鳞状细胞癌中抗菌肽 LL37 的过度表达:癌症预后的肽标志物。

The over expression of cathelicidin peptide LL37 in head and neck squamous cell carcinoma: the peptide marker for the prognosis of cancer.

机构信息

Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India.

出版信息

Cancer Biomark. 2011;10(3-4):125-34. doi: 10.3233/CBM-2012-0238.

DOI:10.3233/CBM-2012-0238
PMID:22674298
Abstract

The over expression of LL37, an antimicrobial peptide belonging~to the cathelicidin family has implication in the progression of human malignancy but the exact role is still not clear. This study aims to elucidate the correlation of LL37 with Head and Neck Squamous Cell Carcinoma (HNSCC) and the consequences of radiotherapy on it. The LL37 levels were quantified in serum samples of control and HNSCC patients at pre-RT, during-RT and post-RT using a real time Surface Plasmon Resonance technology and ELISA. The LL37 of 50 HNSCC patients was significantly (p < 0.0001) threefold higher than the 25 controls and declined with respect to radiation therapy (p < 0.0001) supporting its candidature as a prognostic marker in HNSCC.

摘要

LL37 是一种属于抗菌肽家族的抗菌肽,其过度表达与人类恶性肿瘤的进展有关,但确切的作用尚不清楚。本研究旨在阐明 LL37 与头颈部鳞状细胞癌(HNSCC)的相关性,以及放疗对其的影响。使用实时表面等离子体共振技术和 ELISA 定量检测对照组和 HNSCC 患者在放疗前、放疗期间和放疗后的血清样本中的 LL37 水平。50 例 HNSCC 患者的 LL37 明显(p<0.0001)高于 25 例对照组,且随着放疗而下降(p<0.0001),支持其作为 HNSCC 预后标志物的候选物。

相似文献

1
The over expression of cathelicidin peptide LL37 in head and neck squamous cell carcinoma: the peptide marker for the prognosis of cancer.头颈部鳞状细胞癌中抗菌肽 LL37 的过度表达:癌症预后的肽标志物。
Cancer Biomark. 2011;10(3-4):125-34. doi: 10.3233/CBM-2012-0238.
2
Quantification of p38αMAP kinase: a prognostic marker in HNSCC with respect to radiation therapy.定量分析 p38αMAP 激酶:头颈部鳞癌放疗预后标志物。
Clin Chim Acta. 2012 Jan 18;413(1-2):219-25. doi: 10.1016/j.cca.2011.09.031. Epub 2011 Oct 1.
3
NFκB-p50 as a blood based protein marker for early diagnosis and prognosis of head and neck squamous cell carcinoma.NFκB-p50作为头颈部鳞状细胞癌早期诊断和预后的血液蛋白标志物。
Biochem Biophys Res Commun. 2015 Nov 13;467(2):248-53. doi: 10.1016/j.bbrc.2015.09.181. Epub 2015 Oct 3.
4
Assessment of p38α in peripheral blood mononuclear cells (PBMC): a potential blood protein marker of head and neck squamous cell carcinoma.评估外周血单个核细胞(PBMC)中的 p38α:头颈部鳞状细胞癌的潜在血液蛋白标志物。
Clin Transl Oncol. 2013 Nov;15(11):969-73. doi: 10.1007/s12094-013-1031-3. Epub 2013 Apr 4.
5
Pre-radiotherapy plasma carotenoids and markers of oxidative stress are associated with survival in head and neck squamous cell carcinoma patients: a prospective study.放疗前血浆类胡萝卜素和氧化应激标志物与头颈部鳞状细胞癌患者的生存相关:一项前瞻性研究。
BMC Cancer. 2009 Dec 21;9:458. doi: 10.1186/1471-2407-9-458.
6
Serum biomarkers for detection of head and neck squamous cell carcinoma.用于检测头颈部鳞状细胞癌的血清生物标志物。
Head Neck. 2016 Jan;38(1):9-14. doi: 10.1002/hed.23842. Epub 2015 Jun 26.
7
Pre-therapeutic fibrinogen levels are of prognostic significance in locally advanced head and neck cancer.治疗前纤维蛋白原水平对局部晚期头颈癌具有预后意义。
Wien Klin Wochenschr. 2016 May;128(9-10):320-8. doi: 10.1007/s00508-016-0963-3. Epub 2016 Feb 26.
8
Erratum: Prognostic Value of Routine Blood Markers in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC).勘误:头颈部鳞状细胞癌(HNSCC)患者常规血液标志物的预后价值。
JCO Glob Oncol. 2024 Aug;10:e2400368. doi: 10.1200/GO-24-00368.
9
Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.鳞状细胞癌抗原作为一种预后标志物及其与头颈部鳞状细胞癌临床病理特征的相关性:系统评价和荟萃分析。
J Oral Pathol Med. 2018 Jan;47(1):3-10. doi: 10.1111/jop.12600. Epub 2017 Jul 5.
10
The human cathelicidin LL37 peptide has high plasma levels in B and C hepatitis related to viral activity but not to 25-hydroxyvitamin D plasma level.人源杀菌肽LL37在与病毒活性相关的B型和C型肝炎患者体内血浆水平较高,但与25-羟基维生素D的血浆水平无关。
Rom J Intern Med. 2012 Jul-Sep;50(3):217-23.

引用本文的文献

1
Low-dose calcipotriol can elicit wound closure, anti-microbial, and anti-neoplastic effects in epidermolysis bullosa keratinocytes.低剂量钙泊三醇可诱导大疱性表皮松解症角质形成细胞的伤口闭合、抗菌和抗肿瘤作用。
Sci Rep. 2018 Sep 7;8(1):13430. doi: 10.1038/s41598-018-31823-6.
2
Antimicrobial peptide LL-37 promotes the viability and invasion of skin squamous cell carcinoma by upregulating YB-1.抗菌肽LL-37通过上调YB-1促进皮肤鳞状细胞癌的生存能力和侵袭能力。
Exp Ther Med. 2017 Jul;14(1):499-506. doi: 10.3892/etm.2017.4546. Epub 2017 Jun 6.
3
Antimicrobial peptide LL-37 promotes YB-1 expression, and the viability, migration and invasion of malignant melanoma cells.
抗菌肽LL-37可促进YB-1表达以及恶性黑色素瘤细胞的活力、迁移和侵袭。
Mol Med Rep. 2017 Jan;15(1):240-248. doi: 10.3892/mmr.2016.5978. Epub 2016 Dec 2.
4
Antimicrobial peptide LL-37 promotes the proliferation and invasion of skin squamous cell carcinoma by upregulating DNA-binding protein A.抗菌肽LL-37通过上调DNA结合蛋白A促进皮肤鳞状细胞癌的增殖和侵袭。
Oncol Lett. 2016 Sep;12(3):1745-1752. doi: 10.3892/ol.2016.4865. Epub 2016 Jul 15.
5
Insight into the molecular basis of Schistosoma haematobium-induced bladder cancer through urine proteomics.通过尿液蛋白质组学深入了解埃及血吸虫诱发膀胱癌的分子基础。
Tumour Biol. 2016 Aug;37(8):11279-87. doi: 10.1007/s13277-016-4997-y. Epub 2016 Mar 7.
6
Cathelicidin antimicrobial peptide as a serologic marker and potential pathogenic factor in antineutrophil cytoplasmic antibody-associated vasculitis.作为抗中性粒细胞胞浆抗体相关血管炎的血清学标志物和潜在致病因素的cathelicidin抗菌肽
Arthritis Res Ther. 2014 Feb 28;16(1):105. doi: 10.1186/ar4495.